Iradimed (IRMD) Current Assets (2013 - 2026)

Iradimed (IRMD) has 14 years of Current Assets data on file, last reported at $86.4 million in Q1 2026.

• Quarterly Current Assets rose 15.02% year-over-year to $86.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.4 million (up 15.02% YoY) and the FY2025 annual result came in at $81.2 million, up 7.92% from the prior year.
• Current Assets rose to $86.4 million in Q1 2026 per IRMD's latest filing, from $81.2 million in the prior quarter.
• Across five years, Current Assets topped out at $86.4 million in Q1 2026 and bottomed at $61.3 million in Q1 2023.
• The 5-year median for Current Assets is $74.3 million (2024), against an average of $74.0 million.
• The widest annual swing landed in 2023, when Current Assets fell 6.44%; it then climbed 17.27% in 2024.
• Tracing IRMD's Current Assets over 5 years: stood at $77.5 million in 2022, then slipped by 1.92% to $76.0 million in 2023, then retreated by 1.0% to $75.2 million in 2024, then advanced by 7.92% to $81.2 million in 2025, then increased by 6.43% to $86.4 million in 2026.
• Per Business Quant, the three latest IRMD Current Assets figures stand at $86.4 million (Q1 2026), $81.2 million (Q4 2025), and $84.9 million (Q3 2025).

Peer Comparison